🇺🇸 FDA
Patent

US 8853356

Use of pentagastrin to inhibit gastric acid secretion or as a diuretic

granted A61KA61K38/2207A61P

Quick answer

US patent 8853356 (Use of pentagastrin to inhibit gastric acid secretion or as a diuretic) held by The Regents of the University of California expires Mon Oct 02 2034 00:00:00 GMT+0000 (Coordinated Universal Time). Status: granted.

Key facts

Applicant
The Regents of the University of California
Grant date
Tue Oct 07 2014 00:00:00 GMT+0000 (Coordinated Universal Time)
Expiration
Mon Oct 02 2034 00:00:00 GMT+0000 (Coordinated Universal Time)
Claims
19
CPC classes
A61K, A61K38/2207, A61P, A61P1/00